Literature DB >> 2797079

The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.

D B Dunger1, V Broadbent, E Yeoman, J R Seckl, S L Lightman, D B Grant, J Pritchard.   

Abstract

Diabetes insipidus is a well-recognized complication of Langerhans-cell histiocytosis (histiocytosis X), but its frequency and natural history are not well defined. Of 52 children with histiocytosis whom we studied, 12 (23 percent) had diabetes insipidus. Only two children had diabetes insipidus at presentation with histiocytosis, but the cumulative risk that it would develop during the first four years after the presentation and diagnosis of histiocytosis was found to be 42 percent. Diabetes insipidus occurred most often among children with multisystem disease and those with proptosis. To determine the natural history of diabetes insipidus in children with histiocytosis, we measured the response of urinary arginine vasopressin to water deprivation every six months in 21 children who did not have diabetes insipidus and who had had histiocytosis for less than four years. Five of the 21 children (24 percent) had subnormal responses during the initial test. One subsequently had spontaneous improvement in the functioning of the posterior pituitary, and diabetes insipidus subsequently developed in two, as it did in one of the children who initially had normal function of the posterior pituitary. Two of the children received irradiation to the pituitary within two to four weeks after diabetes insipidus developed, but they had no improvement in pituitary function. However, diabetes insipidus improved transiently during prednisolone therapy in one of these children and improved permanently after etoposide therapy in another child. We conclude that prospective study with the use of a simple water-deprivation test will allow partial defects of posterior-pituitary function to be detected in patients with histiocytosis and will permit a more appropriate evaluation of the effects of therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797079     DOI: 10.1056/NEJM198910263211704

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

1.  Endocrine aspects of Langerhans cell histiocytosis.

Authors:  A T Soliman; I Alsalmi; N E Banna; M Asfour
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.

Authors:  Yoko Shioda; Souichi Adachi; Shinsaku Imashuku; Kazuko Kudo; Toshihiko Imamura; Akira Morimoto
Journal:  Int J Hematol       Date:  2011-11-17       Impact factor: 2.490

3.  Spontaneous gonadotrophin deficiency recovery in an adult patient with Langerhans cell histiocytosis (LCH).

Authors:  Polyzois Makras; Dimitrios Papadogias; George Kontogeorgos; George Piaditis; Gregory A Kaltsas
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH).

Authors:  P Makras; C Samara; M Antoniou; A Zetos; D Papadogias; Z Nikolakopoulou; E Andreakos; G Toloumis; G Kontogeorgos; G Piaditis; G A Kaltsas
Journal:  Neuroradiology       Date:  2005-11-15       Impact factor: 2.804

5.  How I treat Langerhans cell histiocytosis.

Authors:  Carl E Allen; Stephan Ladisch; Kenneth L McClain
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

6.  Langerhans cell histiocytosis--clinical and epidemiological aspects.

Authors:  V Broadbent; R M Egeler; M E Nesbit
Journal:  Br J Cancer Suppl       Date:  1994-09

7.  Growth and Endocrinal Abnormalities in Pediatric Langerhans Cell Histiocytosis.

Authors:  Aashima Dabas; Atul Batra; Rajesh Khadgawat; Viveka P Jyotsna; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2016-03-18       Impact factor: 1.967

8.  Hypertonic saline test for the investigation of posterior pituitary function.

Authors:  A Mohn; C L Acerini; T D Cheetham; S L Lightman; D B Dunger
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

9.  Langerhans cell histiocytosis--a 31 year review.

Authors:  P Leavey; M Varughese; F Breatnach; A O'Meara
Journal:  Ir J Med Sci       Date:  1991-09       Impact factor: 1.568

10.  Pituitary stalk thickening with diabetes insipidus preceding typical manifestations of Langerhans cell histiocytosis in children.

Authors:  S Schmitt; W Wichmann; E Martin; M Zachmann; E J Schoenle
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.